Proteus Digital Health develops digital medicines that collect and aggregate various behavioral, physiological and therapeutic metrics.
Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 1, 2013 | Series F | $62.50M | 1 | — | — | Detail |
May 1, 2001 | Series A | — | 1 | Lycos Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lycos Ventures | Yes | Series A |
Oracle | — | Series F |